Hoffmann-LA Roche is a global leader in personalized healthcare, made unique by its ability to combine pharmaceuticals and diagnostics. The company values treatment choices based on a patient's genetic makeup, believing treatments should be tailored to the biology of patient’s diseases — not just his or her symptoms.
In Canada, Roche stands out as a leader in clinical trial recruitment, accounting for 6% of Roche's global clinical research spending. It focuses on developing medicines and diagnostic tests that will help patients live longer, better lives. Hoffmann-LA Roche strives to address unmet medical needs through early detection and prevention of diseases to diagnosis, treatment, and treatment monitoring.